Kaye Mark
An insider at 1 company in coverage, as reported on Form 4. SEC CIK 1748691. Latest Form 4 filed Oct 23, 2026.
Roles
As stated on the filings: the relationship to the company and any officer title.
| Company | Role | Transactions | First | Latest |
|---|---|---|---|---|
| Elevance Health, Inc.ELV | EVP & CFO, Officer | 13 | 2026-10-22 | 2026-10-22 |
Transactions: 13
Every transaction reported, newest first, including grants, exercises and derivative securities. Purchases and sales (codes P and S) are open-market trades. The reported price is as stated on the form.
What these mean: insiders, Form 4, transaction codes, Rule 10b5-1 plans.
| Date | Company | Transaction | Shares | Reported price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-10-22 | Elevance Health, Inc.EVP & CFO, Officer | Sale | 273 | $447.19 | $122.1k | Form 4 |
| 2026-10-22 | Elevance Health, Inc.EVP & CFO, Officer | Sale | 827 | $446.05 | $368.9k | Form 4 |
| 2026-10-22 | Elevance Health, Inc.EVP & CFO, Officer | Sale | 160 | $444.85 | $71.2k | Form 4 |
| 2026-10-22 | Elevance Health, Inc.EVP & CFO, Officer | Sale | 440 | $443.81 | $195.3k | Form 4 |
| 2026-10-22 | Elevance Health, Inc.EVP & CFO, Officer | Sale | 480 | $442.61 | $212.5k | Form 4 |
| 2026-10-22 | Elevance Health, Inc.EVP & CFO, Officer | Sale | 2,343 | $441.34 | $1.0m | Form 4 |
| 2026-10-22 | Elevance Health, Inc.EVP & CFO, Officer | Sale | 1,720 | $440.44 | $757.6k | Form 4 |
| 2026-10-22 | Elevance Health, Inc.EVP & CFO, Officer | Sale | 1,160 | $439.25 | $509.5k | Form 4 |
| 2026-10-22 | Elevance Health, Inc.EVP & CFO, Officer | Sale | 240 | $438.22 | $105.2k | Form 4 |
| 2026-10-22 | Elevance Health, Inc.EVP & CFO, Officer | Sale | 560 | $437.07 | $244.8k | Form 4 |
| 2026-10-22 | Elevance Health, Inc.EVP & CFO, Officer | Sale | 1,660 | $436.20 | $724.1k | Form 4 |
| 2026-10-22 | Elevance Health, Inc.EVP & CFO, Officer | Sale | 321 | $435.25 | $139.7k | Form 4 |
| 2026-10-22 | Elevance Health, Inc.EVP & CFO, Officer | Sale | 400 | $434.00 | $173.6k | Form 4 |
Source: SEC EDGAR, Forms 4. Last ingested by Listed: Oct 31, 2026, 06:27 ET. Listed shows no prices and gives no investment advice.